| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 01/31/2002 | WO2001044482A3 Optimized t-dna transfer and vectors therefor |
| 01/31/2002 | WO2001038503A3 Novel human protein kinases and protein kinase-like enzymes |
| 01/31/2002 | US20020012982 Recovering preferential protein from solution; incubate protein with matrix, separate and reccover preferential protein |
| 01/31/2002 | US20020012975 Culture product containing Rhodococcus |
| 01/31/2002 | US20020012963 Nucleotide sequences coding preferential peptides; for use in diagnosing and treatment of allergies |
| 01/31/2002 | US20020012962 Nucleotide sequences coding fusion protein for use in the treatment of osteoporosis, cancers, and cachexia |
| 01/31/2002 | US20020012664 Combining agent to be tested, antibody or antigen-binding fragment which binds to amino terminal domain of mammalian CC-chemokine receptor 2, mammalian CC-chemokine receptor 2 or ligand-binding variant, measuring binding |
| 01/31/2002 | US20020012637 Administering to the oral cavity of a human or animal one or more lactic bacteria that are not part of resident microflora of mouth, that are low acidifying, and that are capable of adhering directly to pellicle of teeth |
| 01/31/2002 | DE10034804A1 Verwendung von VLCFAE zum Identifizieren von herbizid wirksamen Verbindungen Using VLCFAE for identifying herbicidally active compounds |
| 01/31/2002 | CA2416159A1 Fermentation process for epothilones |
| 01/30/2002 | EP1176209A1 Production of Sphingomonas exopolysaccharides unattached to the surface of bacterial cells |
| 01/30/2002 | EP1176205A2 Expression of alkaline phosphatase in yeast |
| 01/30/2002 | EP1176203A1 Enzyme with improved NAD(H)-acceptance |
| 01/30/2002 | EP1176201A2 Platelet-specific chimeric immunoglobulin |
| 01/30/2002 | EP1176192A2 Helicobacter felis vaccine |
| 01/30/2002 | EP1175909A2 Therapeutic methods and compositions based on serrate proteins and nucleic acids |
| 01/30/2002 | EP1175502A1 Halo- or hydroxy-substituted nocathiacin antibiotics |
| 01/30/2002 | EP1175500A1 Method for the selective esterification of polyoles |
| 01/30/2002 | EP1175496A1 RECOMBINANT i PENICILLIUM FUNICULOSUM /i FOR HOMOLOGOUS AND HETEROLOGOUS PROTEIN PRODUCTION |
| 01/30/2002 | EP1175486A2 Method for the preservation of viruses and mycoplasma |
| 01/30/2002 | EP1175227A1 Monoclonal antibody directed against cells of human renal cell carcinoma |
| 01/30/2002 | EP1175221A2 Lactic acid bacteria with anxiolytic properties and uses thereof |
| 01/30/2002 | EP0879247A4 Glial cell line-derived neurotrophic factor receptors |
| 01/30/2002 | EP0668913B1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
| 01/30/2002 | EP0617736B1 Use of bacillus thuringiensis isolates for controlling pests in the family aphididae |
| 01/30/2002 | EP0596979B1 Recombinant plant viral nucleic acids |
| 01/30/2002 | EP0528857B1 New bacillus thuringiensis strain and its gene encoding insecticidal toxin |
| 01/30/2002 | EP0497922B1 Infective protein delivery system |
| 01/30/2002 | CN1333837A Methods for producing polypeptides in aspergillus mutant cells |
| 01/30/2002 | CN1333836A Substances WK-5344A and WK-5344B and process for producing the same |
| 01/30/2002 | CN1333833A New method of identifying non-host plant disease resistance genes |
| 01/30/2002 | CN1333832A Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/30/2002 | CN1333831A Polymorphic loci that differentiate escherichia coli 0157:H7 from other strains |
| 01/30/2002 | CN1333825A Subtilase enzymes of the I-S1 I-S2 sub-groups having an additional amino acid residue in an active site loop region |
| 01/30/2002 | CN1333824A Subtilase enzymes of the I-S1 and I-S2 sub-groups having and additional amino acid residue in an active site loop region |
| 01/30/2002 | CN1333823A Subtilase enzymes of the I-S1 and I-S2 sub-groups having an additional amino acid residue in an active site loop region |
| 01/30/2002 | CN1333821A Alpha-amylse variant |
| 01/30/2002 | CN1333820A Recombinant methods and materials for producing epothilone and eopthilone derivatives |
| 01/30/2002 | CN1333819A Method for high level expression of active lymphotoxin-betareceptor immunoglobulin |
| 01/30/2002 | CN1333811A Subtilase enzymes of the I-S1 and I-S2 sub-groups having an additional amino acid residue in the active site loop region |
| 01/30/2002 | CN1333692A I (mycobacterium tuberculosis) superoxide dismutase |
| 01/30/2002 | CN1333688A Method and compositions for improving allogeneic hematopoietic cell transplantation |
| 01/30/2002 | CN1333378A Diagnose test |
| 01/30/2002 | CN1078614C Process for producing high-molecular-weight compounds of phenolic compounds etc, and use thereof |
| 01/30/2002 | CN1078583C Selective process for deacylation of acylated compounds |
| 01/29/2002 | US6342382 Purified nucleic acid; complementarity; washing follow hybridization; genetic engineering and expression |
| 01/29/2002 | US6342374 Human collagenase inhibitor, recombinant vector system for using same and recombinant-DNA method for the manufacture of same |
| 01/29/2002 | US6342368 WD-40-derived peptides and uses thereof |
| 01/29/2002 | US6342229 Used in assays, in diagnostics and in immunotherap y and immunoprophylaxis |
| 01/29/2002 | US6342222 Equine arteritis virus peptides, antibodies and their use in a diagnostic test |
| 01/29/2002 | CA2222909C Detection and quantification of one or more nucleotide sequence target analytes in a sample using spatially localized target analyte replication |
| 01/29/2002 | CA2158575C Chlamydia vaccine and process |
| 01/29/2002 | CA2155330C Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 01/24/2002 | WO2002006503A2 Process for generation of hydrogen gas from various feedstocks using thermophilic bacteria |
| 01/24/2002 | WO2002006494A1 Recombinant plasmid pdsbcm, microorganisms transformed therewith, and method for producing an alkaline protease vapk |
| 01/24/2002 | WO2002006482A1 Receptor protein specifically recognizing bacterial dna |
| 01/24/2002 | WO2002006456A1 Methods and compositions for rapid protein and peptide extraction and isolation using a lysis matrix |
| 01/24/2002 | WO2001064900A3 Aspartate carbamyltransferase as herbicidal target |
| 01/24/2002 | WO2001014417A3 Pesticidal proteins |
| 01/24/2002 | US20020010325 Complexing; purified polypeptide |
| 01/24/2002 | US20020010136 Having an increased positive regulatory activity for expression of tyrosine phenol lyase gene, a gene coding for the same; biosynthesis of L-3,5-dihydroxyphenylalanine (L-DOPA) |
| 01/24/2002 | US20020009800 Genetically engineeered sequences for use in gene therapy of central nervous system |
| 01/24/2002 | US20020009790 Process for stabilizing proteins in an acidic environment with a pectin high-ester |
| 01/24/2002 | US20020009773 Nucleotide sequences coding protein associated with apoptosis; for use in treatment of defects of apoptosis and inflammation |
| 01/24/2002 | US20020009722 Stabilizing agents for preventing the degradation of nucleotide sequences during analysis |
| 01/24/2002 | US20020009708 Reagents and methods for the detection and quantification of vancomycin in biological fluids |
| 01/24/2002 | US20020009707 Method for the inactivation of viruses |
| 01/24/2002 | US20020009450 Administering antagonist to surface receptors |
| 01/24/2002 | US20020009446 Method of modulating memory effector T-cells and compositions |
| 01/24/2002 | US20020009332 Method for soil remediation |
| 01/24/2002 | CA2416377A1 Process for generation of hydrogen gas from various feedstocks using thermophilic bacteria |
| 01/24/2002 | CA2415713A1 Methods and compositions for rapid protein and peptide extraction and isolation using a lysis matrix |
| 01/23/2002 | EP1174523A2 Method for detecting an HBV-derived nucleic acid target sequence |
| 01/23/2002 | EP1174517A2 Use of Very Long Chain Fatty Acid Elongase for the identification of herbicides |
| 01/23/2002 | EP1174515A1 Processes for producing s,s-2-hydroxypropylenediamine-n,n'-disuccinic acid |
| 01/23/2002 | EP1174508A2 Bacterium producing L-glutamic acid and method for producing L-glutamic acid |
| 01/23/2002 | EP1173604A1 Methods, compositions and kits for biological indicator of sterilization |
| 01/23/2002 | EP1173601A1 Heteropolysaccharide produced by pseudomonas sp |
| 01/23/2002 | EP1173597A1 Expression of heterologous genes from an ires translational cassette in retroviral vectors |
| 01/23/2002 | EP1173585A1 Epoxide hydrolases of aspergillus origin |
| 01/23/2002 | EP1173573A1 Method for down-regulating il5 activity |
| 01/23/2002 | EP1173563A1 Compositions and methods for the treatment of tumour |
| 01/23/2002 | EP1173556A1 Forms of prostate specific antigen (psa) specific for benign prostatic hyperplasia (bph) and methods of using such |
| 01/23/2002 | EP1173554A2 Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
| 01/23/2002 | EP1173553A2 Transgenic plant resistant to mycotoxins and methods |
| 01/23/2002 | EP1173545A2 Streptococcus gordonii strains resistant to fluorodeoxyuridine |
| 01/23/2002 | EP1173485A1 Human antibodies to staphylococcus aureus |
| 01/23/2002 | EP1173473A1 Antifungal agents isolated from pseudomonas syringae |
| 01/23/2002 | EP1173471A2 Pseudomycin analogs |
| 01/23/2002 | EP1173465A1 Novel human voltage-gated potassium channel |
| 01/23/2002 | CN1332802A Production of recombinant monellin using methylotrophic yeast expression system |
| 01/23/2002 | CN1332701A Process for treatment of waste water containing heavy metals |
| 01/23/2002 | CN1332375A Method for differentiation and enrichment of cell specific target structure |
| 01/23/2002 | CN1332250A Escherichia coli generating L-arginine and method for production L-arginine |
| 01/23/2002 | CN1332247A Expression vector containing coding expansion enzyme DNA and host cell for its transformation |
| 01/23/2002 | CN1332240A Superoxide dismutase-4 |
| 01/23/2002 | CN1078250C Reshaped monoclonal antibodies against immunoglobulin isotype |
| 01/23/2002 | CN1078249C Microbial method |
| 01/23/2002 | CN1078248C Insulin-secreting cell lines, methods of production and use |
| 01/22/2002 | US6340668 Administering bone morphogenetic protein-11 (bmp-11) to neuronal cells effective to promote the survival of cells |